Literature DB >> 9478986

Cloning of the human equilibrative, nitrobenzylmercaptopurine riboside (NBMPR)-insensitive nucleoside transporter ei by functional expression in a transport-deficient cell line.

C R Crawford1, D H Patel, C Naeve, J A Belt.   

Abstract

Mammalian cells obtain nucleic acid precursors through the de novo synthesis of nucleotides and the salvage of exogenous nucleobases and nucleosides. The first step in the salvage pathway is transport across the plasma membrane. Several transport activities, including equilibrative and concentrative mechanisms, have been identified by their functional properties. We report here the functional cloning of a 2.6-kilobase pair human cDNA encoding the nitrobenzylmercaptopurine riboside (NBMPR)-insensitive, equilibrative nucleoside transporter ei by functional complementation of the transport deficiency in a subline of CEM human leukemia cells. Expression of this cDNA conferred an NBMPR-insensitive, sodium-independent nucleoside transport activity to the cells that exhibited substrate specificity and inhibitor sensitivity characteristic of the ei transporter. The cDNA contained a single open reading frame that encoded a 456-residue protein with 11 potential membrane-spanning regions and two consensus sites for N-glycosylation in the first predicted extracellular loop. The predicted protein was 50% identical to the recently cloned human NBMPR-sensitive, equilibrative nucleoside transporter ENT1 and thus was designated ENT2. Surprisingly, the carboxyl-terminal portion of the ENT2 protein was nearly identical to a smaller protein in the GenBankTM data base (human HNP36, 326 residues) that has been identified as a growth factor-induced delayed early response gene of unknown function. Comparison of the ENT2 and HNP36 nucleotide sequences suggested that HNP36 was translated from a second start codon within the ENT2 open reading frame. Transient expression studies with the full-length ENT2 and a 5'-truncated construct that lacks the first start codon (predicted protein 99% identical to HNP36) demonstrated that only the full-length construct conferred uridine transport activity to the cells. These data suggest that the delayed early response gene HNP36 is a truncated form of ENT2 and that the full-length open reading frame of ENT2 is required for production of a functional plasma membrane ei transporter.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9478986     DOI: 10.1074/jbc.273.9.5288

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  39 in total

Review 1.  Nucleoside transporters in absorptive epithelia.

Authors:  F J Casado; M P Lostao; I Aymerich; I M Larráyoz; S Duflot; S Rodríguez-Mulero; M Pastor-Anglada
Journal:  J Physiol Biochem       Date:  2002-12       Impact factor: 4.158

Review 2.  The role of transporters in the toxicity of nucleoside and nucleotide analogs.

Authors:  Christopher A Koczor; Rebecca A Torres; William Lewis
Journal:  Expert Opin Drug Metab Toxicol       Date:  2012-04-18       Impact factor: 4.481

3.  ENT1 regulates ethanol-sensitive EAAT2 expression and function in astrocytes.

Authors:  Jinhua Wu; Moonnoh R Lee; Sun Choi; Taehyun Kim; Doo-Sup Choi
Journal:  Alcohol Clin Exp Res       Date:  2010-04-05       Impact factor: 3.455

4.  Dipyridamole analogs as pharmacological inhibitors of equilibrative nucleoside transporters. Identification of novel potent and selective inhibitors of the adenosine transporter function of human equilibrative nucleoside transporter 4 (hENT4).

Authors:  Chunmei Wang; Wenwei Lin; Hilaire Playa; Shan Sun; Keyuna Cameron; John K Buolamwini
Journal:  Biochem Pharmacol       Date:  2013-09-07       Impact factor: 5.858

Review 5.  ABC transporters and their role in nucleoside and nucleotide drug resistance.

Authors:  Yu Fukuda; John D Schuetz
Journal:  Biochem Pharmacol       Date:  2012-01-20       Impact factor: 5.858

6.  Functional characterization and expression analysis of a gene, OsENT2, encoding an equilibrative nucleoside transporter in rice suggest a function in cytokinin transport.

Authors:  Naoya Hirose; Nobue Makita; Tomoyuki Yamaya; Hitoshi Sakakibara
Journal:  Plant Physiol       Date:  2005-04-22       Impact factor: 8.340

Review 7.  Transporters at CNS barrier sites: obstacles or opportunities for drug delivery?

Authors:  Lucy Sanchez-Covarrubias; Lauren M Slosky; Brandon J Thompson; Thomas P Davis; Patrick T Ronaldson
Journal:  Curr Pharm Des       Date:  2014       Impact factor: 3.116

8.  Novel nuclear hENT2 isoforms regulate cell cycle progression via controlling nucleoside transport and nuclear reservoir.

Authors:  Natalia Grañé-Boladeras; Christopher M Spring; W J Brad Hanna; Marçal Pastor-Anglada; Imogen R Coe
Journal:  Cell Mol Life Sci       Date:  2016-06-06       Impact factor: 9.261

Review 9.  The equilibrative nucleoside transporter family, SLC29.

Authors:  Stephen A Baldwin; Paul R Beal; Sylvia Y M Yao; Anne E King; Carol E Cass; James D Young
Journal:  Pflugers Arch       Date:  2003-06-28       Impact factor: 3.657

10.  Interferon-gamma regulates nucleoside transport systems in macrophages through signal transduction and activator of transduction factor 1 (STAT1)-dependent and -independent signalling pathways.

Authors:  Concepció Soler; Antonio Felipe; José García-Manteiga; Maria Serra; Elena Guillén-Gómez; F Javier Casado; Carol MacLeod; Manuel Modolell; Marçal Pastor-Anglada; Antonio Celada
Journal:  Biochem J       Date:  2003-11-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.